Fabian Knörr

Fabian Knörr is a Medical Specialist in Pediatrics and Youth Medicine at the Hamburg University Medical Center (UKE), affiliated with the Department of Pediatric Hematology and Oncology within the Faculty of Medicine. His work focuses on pediatric oncology and hematology, particularly in the diagnosis and treatment of hematologic malignancies like anaplastic large cell lymphoma (ALCL) and Burkitt lymphoma. He is actively involved in international clinical trials through collaborations such as the NHL-BFM Study Group.

Knörr’s research emphasizes molecular diagnostics, targeted therapies (e.g., crizotinib), and immune response mechanisms in pediatric cancers. He has contributed to studies on minimal residual disease monitoring via PCR techniques and the role of genetic markers like ALK fusions. His work bridges clinical practice and translational research, aiming to improve outcomes for children with relapsed or refractory cancers.

Publications highlight his expertise in therapeutic protocols, such as stem cell transplantation and combination therapies, as well as the development of prognostic and diagnostic tools. Collaborations with international teams underscore his commitment to advancing global pediatric oncology standards.